Arbeitsgebiete
Zelluläre Signalwege, Tumorbiologie, Biomarker-Identifizierung und Validierung, Assayentwicklung, miniaturisierte Assaysysteme
Werdegang mit den wichtigsten Stationen
2003 - heute Gruppenleiter Assayentwicklung
2000 - heute NMI
1996 - 2000 Wissenschaftlicher Mitarbeiter, Max-Planck-Institut für Entwicklungsbiologie, Tübingen
1994 - 1995 Postdoktorand, ICMB, University of Edinburgh, Scotland, UK
Dr. Markus Templin
Diplom-Biologe
Projekte
Publikationen
-
Cell Type-Specific Anti-Adhesion Properties of Peritoneal Cell Treatment with Plasma-Activated Media (PAM)Holl, M., Rasch, M., Becker, L., Keller, A., Schultze-Rhonhof, L., Ruoff, F., Templin, M., Keller, S., Neis, F., Keßler, F., Andress, J., Bachmann, C., Krämer, B., Schenke-Layland, K., Brucker, S., Marzi, J., Weiss, M.10.3390/biomedicines10040927
-
Noninvasive Physical Plasma as Innovative and Tissue-Preserving Therapy for Women Positive for Cervical Intraepithelial NeoplasiaMarzi, J., Stope, M., Henes, M., Koch, A., Wenzel, T., Holl, M., Layland, S., Neis, F., Bösmüller, H., Ruoff, F., Templin, M., Krämer, B., Stäbler, A., Barz, J., Berrio, D., Enderle, M., Loskill, P., Brucker, S., Schenke-Layland, K., Weiss, M.10.3390/cancers14081933
-
Off-target lipid metabolism disruption by the mouse constitutive androstane receptor ligand TCPOBOP in humanized miceSkoda J, Dohnalova K, Chalupsky K, Stahl A, Templin M, Maixnernova J, Micuda S, Grontved L, Bräuning A, Pavek PVolume 197, March 2022, 114905; https://doi.org/10.1016/j.bcp.2021.114905
-
Altered Proinflammatory Responses to Polyelectrolyte Multilayer Coatings Are Associated with Differences in Protein Adsorption and WettabilityBilling F, Walter B, Fink S, Arefaine E, Pickarski L, Maier S, Kretz R, Jakobi M, Feuerer N, Schneiderhan-Marra N, Burkhardt C, Templin M, Zeck A, Krastev R, Hartmann H, Shipp C.ACS Appl Mater Interfaces. 2021 Nov 24;13(46):55534-55549. doi: 10.1021/acsami.1c16175. Epub 2021 Nov 11. PMID: 34762399.
-
Targeted Protein Profiling of In Vivo NIPP-Treated Tissues Using DigiWest TechnologyRuoff, F.; Henes, M.; Templin, M.; Enderle, M.; Bösmüller, H.; Wallwiener, D.; Brucker, S.Y.; Schenke-Layland, K.; Weiss, M.Appl. Sci. 2021, 11, 11238. https://doi.org/10.3390/app112311238
-
Characterization of hepatic zonation in mice by mass-spectrometric and antibody-based proteomics approachesKling S, Lang B, Hammer HS, Naboulsi W, Sprenger H, Frenzel F, Pötz O, Schwarz M, Braeuning A, Templin MFBiol Chem. 2021 Oct 4. doi: 10.1515/hsz-2021-0314. Epub ahead of print. PMID: 34599868.
-
Tris(hydroxymethyl)aminomethane Compatibility with N-Hydroxysuccinimide Ester Chemistry: Biotinylation of Peptides and Proteins in TRIS BufferKratzer U, Sommersdorf C, Maier S, Wagner TR, Templin M, Joos TO, Rothbauer U, Zeck A, Poetz OBioconjug Chem. 2021 Sep 15;32(9):1960-1965. doi: https://doi.org/10.1021/acs.bioconjchem.1c00283. Epub 2021 Aug 18. PMID: 34406760.
-
Advancement of precision oncology by integration of highly sensitive protein profiling technologies and patient-derived cell models for functional efficacy testingPawlak, M., Templin, M., & Schmees, C.Immuno-Oncology Insights, 2(4), 171–185. https://doi.org/10.18609/ioi.2021.013
-
Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 PatientsRuetalo N, Businger R, Althaus K, Fink S, Ruoff F, Pogoda M, Iftner A, Ganzenmüller T, Hamprecht K, Flehmig B, Bakchoul T, Templin MF, Schindler MmSphere. 2021 Feb 24;6(1):e01145-20. doi: 10.1128/mSphere.01145-20. PMID: 33627511; PMCID: PMC8544894.
-
Nidogen-1 Mitigates Ischemia and Promotes Tissue Survival and RegenerationZbinden A, Layland SL, Urbanczyk M, Carvajal Berrio DA, Marzi J, Zauner M, Hammerschmidt A, Brauchle EM, Sudrow K, Fink S, Templin M, Liebscher S, Klein G, Deb A, Duffy GP, Crooks GM, Eble JA, Mikkola HKA, Nsair A, Seifert M, Schenke-Layland KAdv Sci (Weinh). 2020 Dec 21;8(4):2002500. doi: 10.1002/advs.202002500. PMID: 33643791; PMCID: PMC7887579.
-
Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D culturesSchumacher D, Andrieux G, Boehnke K, Keil M, Silvestri A, Silvestrov M, Keilholz U, Haybaeck J, Erdmann G, Sachse C, Templin M, Hoffmann J, Boerries M, Schafer R, Regenbrecht CRAPLoS Genet 15(3): e1008076. https://doi.org/10.1371/journal.pgen.1008076
-
Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D culturesSchumacher D, Andrieux G, Boehnke K, Keil M, Silvestri A, Silvestrov M, Keilholz U, Haybaeck J, Erdmann G, Sachse C, Templin M, Hoffmann J, Boerries M, Schäfer R, Regenbrecht CPLoS Genet 15(3): e1008076.
-
Mouse Hepatomas with Ha-ras and B-raf Mutations Differ in Mitogen-Activated Protein Kinase Signaling and Response to Constitutive Androstane Receptor ActivationBraeuning A, Kollotzek F, Zeller E, Knorpp T, Templin MF, Schwarz MDrug Metab Dispos. 2018 Nov;46(11):1462-1465. doi: 10.1124/dmd.118.083014. Epub 2018 Aug 16.
-
A high-throughput pipeline for validation of antibodiesSikorski K, Mehta A, Inngjerdingen M, Thakor F, Kling S, Kalina T, Nyman TA, Stensland ME, Zhou W, de Souza GA, Holden L, Stuchly J, Templin M, Lund-Johansen FNat Methods. 2018 Nov;15(11):909-912. doi: 10.1038/s41592-018-0179-8. Epub 2018 Oct 30.
-
Peptide-Based Sandwich Immunoassay for the Quantification of the Membrane Transporter Multidrug Resistance ProteinPoetz O, Dieze T, Hammer H, Weiß F, Sommersdorf C, Templin MF, Esdar C, Zimmermann A, Stevanovic S, Bedke J, Stenzl A, Joos TO.Anal Chem. 2018 May 1;90(9):5788-5794. doi: 10.1021/acs.analchem.8b00152. Epub 2018 Apr 12.
-
Epidermal Growth Factor Represses Constitutive Androstane Receptor Expression in Primary Human Hepatocytes and Favors Regulation by Pregnane X Receptor.de Boussac H, Gondeau C, Briolotti P, Duret C, Treindl F, Römer M, Fabre JM, Herrero A, Ramos J, Maurel P, Templin M, Gerbal-Chaloin S, Daujat-Chavanieu MDrug Metab Dispos. 2018 Mar;46(3):223-236. doi: 10.1124/dmd.117.078683. Epub 2017 Dec 21.
-
Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: Single versus repeated exposureWaizenegger J, Braeuning A, Templin M, Lampen A, Hessel-Pras SFood Chem Toxicol. 2018 Apr;114:215-226. doi: 10.1016/j.fct.2018.02.036. Epub 2018 Feb 16.
-
Platelet protein biomarker panel for ovarian cancer diagnosisLomnytska M, Pinto R, Becker S, Engström U, Gustafsson S, Björklund C, Templin M, Bergstrand J, Xu L, Widengren J, Epstein E, Franzén B, Auer G.Biomark Res. 2018 Jan 12;6:2. doi: 10.1186/s40364-018-0118-y.
-
Impact of serum and dialysates obtained from chronic hemodialysis patients maintained on high cut-off membranes on inflammation profile in human THP-1 monocytesTrojanowicz B, Ulrich C, Fiedler R, Storr M, Boehler T, Martus P, Pawlak M, Glomb MA, Henning C, Templin M, Werner K, Zickler D, Willy K, Schindler R, Girndt MHemodial Int. 2017 Jul;21(3):348-358. doi: 10.1111/hdi.12494. Epub 2016 Sep 26.
-
Miniaturized Multiplexed Protein Binding AssaysTemplin MF, Poetz O, Schwenk JM, Stoll D, Joos TOW.-L. Xing and J. Cheng. Frontiers in Biochip Technology. Boston, MA: Springer US; 2006. 61-87.
-
Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical TrialZickler D, Schindler R, Willy K, Martus P, Pawlak M, Storr M, Hulko M, Boehler T, Glomb MA, Liehr K, Henning C, Templin M, Trojanowicz B, Ulrich C, Werner K, Fiedler R, Girndt MPLoS One. 2017 Jan 13;12(1):e0169024. doi: 10.1371/journal.pone.0169024. eCollection 2017.
-
Coordinating Role of RXRalpha in Downregulating Hepatic Detoxification during Inflammation Revealed by Fuzzy-Logic ModelingKeller R, Klein M, Thomas M, Drager A, Metzger U, Templin MF, Joos TO, Thasler WE, Zell A, Zanger UMPLoS Comput Biol. 2016 Jan 4;12(1):e1004431. doi: 10.1371/journal.pcbi.1004431. eCollection 2016 Jan.
-
High cut-off dialysis in chronic haemodialysis patientsGirndt M, Fiedler R, Martus P, Pawlak M, Storr M, Bohler T, Glomb MA, Liehr K, Henning C, Templin M, Trojanowicz B, Ulrich C, Werner K, Zickler D, Schindler REur J Clin Invest. 2015 Dec;45(12):1333-40. doi: 10.1111/eci.12559.
-
RPPApipe: a pipeline for the analysis of reverse-phase protein array dataEichner J, Heubach Y, Ruff M, Kohlhof H, Strobl S, Mayer B, Pawlak M, Templin MFBiosystems. 2014 Aug;122:19-24. doi: 10.1016/j.biosystems.2014.06.009. Epub 2014 Jun 18.
-
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast CancerSchneck, H., Gierke, B., Uppenkamp, F., Behrens, B., Niederacher, D., Stoecklein, N. H., Templin, M. F., Pawlak, M., Fehm, T., Neubauer, H.Proteomics, 9(13), 3535–3548. https://doi.org/10.1002/pmic.200800159
-
A bead-based western for high-throughput cellular signal transduction analysesTreindl F, Ruprecht B, Beiter Y, Schultz S, Dottinger A, Staebler A, Joos TO, Kling S, Poetz O, Fehm T, Neubauer H, Kuster B, Templin MFNat Commun. 2016 Sep 23;7:12852. doi: 10.1038/ncomms12852.
-
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast CancerSchneck H, Gierke B, Uppenkamp F, Behrens B, Niederacher D, Stoecklein NH, Templin MF, Pawlak M, Fehm T, Neubauer HPLoS One. 2015 Dec 22;10(12):e0144535. doi: 10.1371/journal.pone.0144535. eCollection 2015.
-
Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometryWeiß F, Schnabel A, Planatscher H, van den Berg BHJ, Serschnitzki B, Nuessler AK, Thasler WE, Weiss TS, Reuss M, Stoll D, Templin MF, Joos TO, Marcus K, Poetz OSci Rep. 2015 Mar 4;5:8759. doi: 10.1038/srep08759.
-
Bead-Based Peptide Arrays for Profiling the Specificity of Modification State-Specific AntibodiesFilomena A, Beiter Y, Templin MF, Joos TO, Schneiderhan-Marra N, Poetz OMethods Mol Biol. 2015;1348:251-65. doi: 10.1007/978-1-4939-2999-3_22.
-
Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in ratRomer M, Eichner J, Metzger U, Templin MF, Plummer S, Ellinger-Ziegelbauer H, Zell APLoS One. 2014 May 15;9(5):e97640. doi: 10.1371/journal.pone.0097640. eCollection 2014.
-
Ha-ras and β-Catenin oncoproteins orchestrate metabolic programs in mouse liver tumorsUnterberger EB, Eichner J, Wrzodek C, Lempiäinen H, Luisier R, Terranova R, Metzger U, Plummer S, Knorpp T, Braeuning A, Moggs J, Templin MF, Honndorf V, Piotto M, Zell A, Schwarz MInternational Journal of Cancer. 2014 Oct 1; 135(7): 1574-1585. https://doi.org/10.1002/ijc.28798
-
Multiple Protein Analysis of Formalin-fixed and Paraffin-embedded Tissue Samples with Reverse phase Protein ArraysAssadi M, Lamerz J, Jarutat T, Farfsing A, Paul H, Gierke B, Breitinger E, Templin MF, Essioux L, Arbogast S, Venturi M, Pawlak M, Langen H, Schindler TMol Cell Proteomics. 2013 Sep;12(9):2615-22. doi: 10.1074/mcp.M112.023051. Epub 2013 May 7.
-
Multiple protein analysis of FFPE tissue samples with reverse-phase protein arraysAssadi M, Lamerz J, Jarutat T, Farfsing A, Paul H, Gierke B, Breitinger E, Templin MF, Essioux L, Arbogast S, Venturi M, Pawlak M, Langen H, Schindler TMol Cell Proteomics. 2013 Sep;12(9):2615-22. doi: 10.1074/mcp.M112.023051. Epub 2013 May 7.
-
From spots to beads-PTM-peptide bead arrays for the characterization of anti-histone antibodiesHeubach Y, Planatscher H, Sommersdorf C, Maisch D, Maier J, Joos TO, Templin MF, Poetz OProteomics. 2013 Mar;13(6):1010-5. doi: 10.1002/pmic.201200383.
-
Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotionLempiainen H, Couttet P, Bolognani F, Muller A, Dubost V, Luisier R, Del Rio Espinola A, Vitry V, Unterberger EB, Thomson JP, Treindl F, Metzger U, Wrzodek C, Hahne F, Zollinger T, Brasa S, Kalteis M, Marcellin M, Giudicelli F, Braeuning A, Morawiec L, Zamurovic N, Langle U, Scheer N, Schubeler D, Goodman J, Chibout SD, Marlowe J, Theil D, Heard DJ, Grenet O, Zell A, Templin MF, Meehan RR, Wolf RC, Elcombe CR, Schwarz M, Moulin P, Terranova R, Moggs JGToxicol Sci. 2013 Feb;131(2):375-86. doi: 10.1093/toxsci/kfs303. Epub 2012 Oct 22.
-
Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysisVolk S, Schreiber TD, Eisen D, Wiese C, Planatscher H, Pynn CJ, Stoll D, Templin MF, Joos TO, Poetz OMol Cell Proteomics. 2012 Jul;11(7):O111.015438. Epub 2012 Apr 23.
-
A Comprehensive Small Interfering RNA Screen Identifies Signaling Pathways Required for Gephyrin ClusteringWuchter J, Beuter S, Treindl F, Herrmann T, Zeck G, Templin MF, Volkmer HThe Journal of Neuroscience. 2012 Oct 17; 32(42):14821–14834
-
Minimum information about a protein affinity reagent (MIAPAR)Bourbeillon J, Orchard S, Benhar I, Borrebaeck C, Templin M, de Daruvar A, Dubel S, Frank R, Gibson F, Gloriam D, Haslam N, Hiltker T, Humphrey-Smith I, Hust M, Juncker D, Koegl M, Konthur Z, Korn B, et al.NatBiotechnol. 2010 Jul;28(7):650-3. doi: 10.1038/nbt0710-650.
-
Targeting peptide termini - a novel immunoaffinity approach to reduce complexity in mass spectrometric protein identificationHoeppe S, Schreiber TD, Planatscher H, Zell A, Templin MF, Stoll D, Joos TO, Poetz OMol Cell Proteomics. 2011 Feb;10(2):M110.002857. doi: 10.1074/mcp.M110.002857. Epub 2010 Oct 20.
-
Optimal selection of epitopes for TXP-immunoaffinity mass spectrometryPlanatscher H, Supper J, Poetz O, Stoll D, Joos T, Templin MF, Zell AAlgorithms Mol Biol. 2010 Jun 25;5:28. doi: 10.1186/1748-7188-5-28
-
Sequential multiplex analyte capturing for phosphor-protein profilingPoetz O, Henzler T, Hartmann M, Kazmaier C, Templin MF, Herget T, Joos TOMol Cell Proteomics. 2010 Nov; 9(11): 2474–2481. Published online 2010 Aug 3. doi: 10.1074/mcp.M110.002709
-
Protein microarrays for diagnostic assays.Hartmann M, Roeraade J, Stoll D, Templin MF, Joos TOAnal Bioanal Chem. 2009 Mar;393(5):1407-16. Epub 2008 Sep 20. doi: 10.1007/s00216-008-2379-z.
-
On display on a bug: a systematic approach to characterize antibodiesKnorpp T, Templin MFNat Methods. 2008 Dec;5(12):1003-4. DOI: 10.1038/nmeth1208-1003
-
Novel functional profiling approach combining reverse phase protein microarrays and human 3-D ex vivo tissue cultures: expression of apoptosis-related proteins in human colon cancer.Pirnia F, Pawlak M, Thallinger GG, Gierke B, Templin MF, Kappeler A, Betticher DC, Gloor B, Borner MMProteomics. 2009 Jul;9(13):3535-48. doi: 10.1002/pmic.200800159.
-
Proteome wide screening using peptide affinity capturePoetz O, Hoeppe S, Templin MF, Stoll D, Joos TOProteomics. 2009 Mar;9(6):1518-23. doi: 10.1002/pmic.200800842.
-
Tumor promotion in liver of mice with a conditional Cx26 knockout.Marx-Stoelting P, Mahr J, Knorpp T, Schreiber S, Templin MF, Ott T, Buchmann A, Schwarz MToxicol Sci. 2008 Jun;103(2):260-7. Epub 2008 Feb 27. doi: 10.1093/toxsci/kfn043
-
Expanding assay dynamics: a combined competitive and direct assay system for the quantification of proteins in multiplexed immunoassaysHartmann M, Schrenk M, Dottinger A, Nagel S, Roeraade J, Joos TO, Templin MFClin Chem. 2008 Jun;54(6):956-63. Epub 2008 Apr 24. doi: 10.1373/clinchem.2007.099812
-
Increasing robustness and sensitivity of protein microarrays through microagitation and automation.Hartmann M, Toegl A, Kirchner R, Templin MF, Joos TOAnal Chim Acta. 2006 Mar 30;564(1):66-73. Epub 2006 Feb 21. DOI: 10.1016/j.aca.2006.01.041
-
Protein Microarrays - Neue Systeme für die ProteomforschungJoos TO, Pawlak M, Templin M, Stoll DGIT Labor-Fachzeitschrift. 2006; 10, page 890-892.
-
Protein microarrays: applications and future challengesStoll D, Templin MF, Bachmann J, Joos TOCurr Opin Drug Discov Devel. 2005 Mar;8(2):239-52.
-
Protein Microarrays - A Promising Tool for Cancer DiagnosisSchneiderhan-Marra N, Kirn A, Döttinger A, Templin M, Sauer G, Deissler H, Joos TOCancer Genomics & Proteomics. 2005 Jan; 2(1): 37-42.
-
Protein microarrays: catching the proteome.Poetz O, Schwenk JM, Kramer S, Stoll D, Templin MF, Joos TOMech Ageing Dev. 2005 Jan;126(1):161-70. DOI: 10.1016/j.mad.2004.09.030
-
Protein microarrays for antibody profiling: Specificity and affinity determination on a chip.Poetz O, Ostendorp R, Brocks B, Schwenk JM, Stoll D, Joos TO, Templin MFProteomics. 2005 Jun;5(9):2402-11. DOI: 10.1002/pmic.200401299
-
Protein microarrays and multiplexed sandwich immunoassays: what beats the beads?Templin MF, Stoll D, Bachmann J, Joos TOComb Chem High Throughput Screen. 2004 May;7(3):223-9.
-
Microarray technology: an increasing variety of screening tools for proteomic research.Stoll D, Bachmann J, Templin MF, Joos TODDT:Targets. 2004 Dec 15; 9(24): 10-7
-
Protein microarrays: promising tools for proteomic researchTemplin MF, Stoll D, Schwenk JM, Pötz O, Kramer S, Joos TOProteomics. 2003 Nov;3(11):2155-66.